ICU · Rehabilitation
Acute severe community-acquired pneumonia:CAP readmission and recurrence prevention
Also known as CAP readmission prevention · CAP recurrence · Post-discharge complications · CAP prevention strategies · 30-day pneumonia readmission · Post-pneumonia discharge bundle
CAP readmission rate is 10-20% within 30 days and is a widely tracked hospital quality metric (target <15%, with high-performing centres aiming <12%). Causes: incomplete recovery, complications (empyema, abscess), comorbidity exacerbation (COPD, heart failure), secondary infection, medication non-adherence, premature return to activity. Recurrence rate: 8-15% within 1 year (higher in: elderly, COPD, heart failure, diabetes, CKD, dementia, immunocompromised, smokers, structural lung disease, social isolation, poor functional status, previous CAP hospitalisation, aspiration risk). Prevention strategies: (1) Complete antibiotic course. (2) Smoking cessation. (3) Vaccination (pneumococcal PCV13/PCV20 + PPSV23, influenza annual, COVID, RSV in elderly). (4) Treat underlying conditions (COPD optimisation, dental care for aspiration risk, heart-failure and diabetes optimisation). (5) Gradual return to activity. (6) Follow-up (GP within 7 days, CXR 6 weeks). (7) Patient education (warning signs, written action plan). (8) Pulmonary rehabilitation. (9) Address PICS (physical + cognitive impairment increases readmission risk). (10) Structured discharge bundle (medication reconciliation, follow-up appointment scheduled before discharge, vaccination offered, smoking-cessation referral, deterioration action plan).
On this page & tools
Your progress
Saved locally on this device.
Target exams
Red flags
Why this matters: the 30-day readmission target
Community-acquired pneumonia is one of the commonest reasons for unplanned hospital readmission, and the 30-day all-cause readmission rate has become a publicly reported, financially penalised quality metric in many health systems.[2][3] Real-world cohorts put the figure at 10-20% within 30 days and 20-30% within 90 days, with readmitted patients carrying roughly double the one-year mortality of those who stay out of hospital.[2][4] The pragmatic service target is a 30-day readmission rate below 15%, with high-performing centres and bundled-care programmes aiming for <12%.[15] Roughly half of early readmissions are judged potentially avoidable — driven by incomplete recovery, comorbidity decompensation, medication errors, failed social support, or missed follow-up — which is why a structured prevention and discharge bundle moves the needle far more than any single intervention.[2][15]
The critical conceptual shift for the exam: readmission is rarely a single failure. It is the convergence of (a) patient vulnerability (age, comorbidity, frailty, social isolation), (b) incomplete physiological recovery at the moment of discharge, and (c) system gaps (no follow-up, medication errors, no action plan). Prevention must therefore be multicomponent and bundled, not a single "magic bullet".[5][15]
Exam practice
SAQ — Preventing 30-day readmission after severe CAP
10 minutes · 10 marks
A 74-year-old man is on the ward recovering from severe community-acquired pneumonia (Strep pneumoniae, bacteraemic) that required 4 days in ICU for type 1 respiratory failure. He has COPD (FEV1 45% predicted), heart failure (EF 35%), type 2 diabetes, and stage 3 CKD. He lives alone since his wife died 6 months ago, smokes 20 cigarettes/day, and was admitted to hospital with pneumonia 14 months ago. His LACE score is 12. Outline your plan to prevent readmission.
Clinical pearls
Readmission risk factors
Risk factors for early CAP readmission separate into non-modifiable patient characteristics (which flag who needs the heaviest bundle) and modifiable/clinical factors (which the bundle actually targets). The strongest individual predictors across cohorts are age >65, the number of comorbidities, prior CAP admission, severe initial presentation (ICU/PSI class IV-V), and social isolation.[2][3][4]
Non-modifiable vs modifiable readmission risk factors
Non-modifiable (flag for intensive bundle)
Set the baseline risk
- Age >65 (risk rises steeply >75); the single biggest demographic driver
- Male sex, low socioeconomic status, low health literacy
- Comorbidity burden — COPD, heart failure, diabetes, CKD, chronic liver disease, dementia
- Previous CAP hospitalisation (recurrent pneumonias cluster in the same patient)
- Severe index admission — ICU stay, mechanical ventilation, bacteraemia, PSI/ CURB-65 high class
- Frailty / poor baseline functional status / Barthel <60 / need for activities-of-daily-living assistance
- Social isolation — lives alone, no carer, poor social support, recent bereavement
- Nursing-home or residential-care residence (healthcare-associated exposure, multidrug-resistant organisms)
Modifiable (the bundle targets these)
Where prevention actually acts
- Incomplete recovery at discharge — discharging before clinical stability criteria are met
- Uncontrolled comorbidity — decompensated heart failure, hyperglycaemia, COPD exacerbation smouldering
- Medication non-adherence and prescription errors at transitions (duplicate/omitted/interacting drugs)
- Smoking — current smoking roughly doubles CAP recurrence and readmission risk
- Missed / late vaccination — pneumococcal, influenza, COVID, RSV
- Untreated dysphagia / silent aspiration — the commonest driver of "recurrent" pneumonia in the elderly
- Malnutrition and ICU-acquired weakness — sarcopenia delays recovery and drives readmission
- No follow-up arranged, no written deterioration action plan, no carer education
The comorbidity cocktail most likely to bring a patient back is the pulmonary–cardiac–metabolic triad: COPD + chronic heart failure + diabetes/CKD. Each adds an independent odds ratio of roughly 1.3-1.8 for 30-day readmission, and the combination is multiplicative.[3] Dementia deserves special mention because it predicts readmission not through the lung but through aspiration, missed medications, and delayed presentation — it is the bridge between the "comorbidity" and "aspiration risk" categories.[11]
The comorbidity profile and how each drives readmission
COPD
Airflow limitation + exacerbations
- Baseline airway inflammation and colonisation lower the threshold for a new infection to tip into pneumonia
- Post-CAP exacerbation of COPD is a top-three cause of 30-day readmission
- Mitigation: optimise inhaler technique, add pulmonary rehab, give an exacerbation action plan and standby oral corticosteroid/antibiotic pack
Heart failure
The "cardiac pneumonia"
- Pulmonary venous congestion mimics, worsens and follows pneumonia — fluid overload post-CAP is a classic readmission trigger
- A "recurrent pneumonia" in a heart-failure patient is often recurring pulmonary oedema, not infection
- Mitigation: diuretic optimisation, daily-weight and oedema education, early cardiology review, BNP-guided therapy where available
Diabetes / CKD
Immune + metabolic vulnerability
- Hyperglycaemia impairs neutrophil function and predicts poor CAP outcomes and recurrence
- CKD alters antibiotic dosing (toxicity vs underdosing) and fluid handling
- Mitigation: tight-but-safe glycaemic control at discharge, renal dose-adjust all discharge antibiotics, nephrology follow-up
Dementia / neurological
Aspiration and adherence
- Dysphagia, poor dentition and impaired cough drive recurrent aspiration pneumonia
- Reduced capacity for self-management and medication adherence
- Mitigation: formal swallow assessment (SLT), texture-modified diet, supervised medications, carer education, dental review
Causes of 30-day readmission
When a patient bounces back, the readmission is pneumonia-related in only ~40-50% of cases; the remainder are comorbidity decompensation, other infections, cardiovascular events, or social/system failures.[3][4] This matters because a discharge bundle that only addresses the index infection will miss half the problem.
Pneumonia-related vs unrelated readmission
Pneumonia-related (40-50%)
Incomplete recovery or recurrence
- Genuine relapse — initial organism not eradicated (too-short course, resistant organism, undrained focus)
- Secondary / superimposed infection — new organism, often nosocomial or post-viral (influenza then Staph/pneumococcus)
- Complication declared late — empyema, lung abscess, metastatic infection (endocarditis, septic arthritis)
- Non-resolving pneumonia — wrong diagnosis all along (malignancy, TB, organising pneumonia, pulmonary embolism)
Comorbidity decompensation (25-35%)
The index illness tipped another system
- Acute exacerbation of COPD — the commonest single non-pneumonia cause
- Acute decompensated heart failure / atrial fibrillation — fluid shifts, sepsis-related myocardial stunning
- Hyperglycaemia / DKA / HHS in diabetes; electrolyte and volume issues in CKD
- Delirium or functional decline in the frail elderly ("off legs", falls, dehydration)
System / social (15-25%)
Potentially avoidable
- Medication error at transition — wrong drug, wrong dose, omitted drug, duplicate therapy
- No follow-up, no action plan — patient and family re-presented with anxiety or mild deterioration
- Failed social discharge — no carer, cannot obtain medications, cannot cope at home
- Premature discharge against stability criteria
Risk stratification at discharge
Two validated, quick tools help triage who needs the heaviest post-discharge bundle.[2]
HOSPITAL score vs LACE index for readmission risk
HOSPITAL score
7 variables, derived in-hospital
- H — Haematocrit <30% (low at discharge)
- O — Oncology (active cancer) — discharged from an oncology service
- S — Sodium <135 mmol/L at discharge
- P — Procedure (any invasive procedure during admission)
- I — Index admission (admitted through ED / urgent) and Intensive-care stay
- T — Number of admissions in past year (0, 1-2, 3-5, >5)
- A — Low haemoglobin (anaemia) — combined with H above
- L — Low Discharge from oncology — captured under O
- Score >=5 = high risk (>=20% 30-day readmission) — target for an intensive bundle
LACE index
4 variables, usable at/after discharge
- L — Length of stay (acute days): 1, 2-3, 4-6, 7-13, >=14 → 0/1-4/6/10 points
- A — Acuity of admission: emergency = 3 points
- C — Comorbidity (Charlson): none, low (1), moderate (2-3), high >=4 → 0/1/2/3
- E — Emergency department visits in prior 6 months: 0, 1, 2, 3, >=4 → 0/1/2/3/4
- Total >=10 = high risk (readmission ~20%); >=14 very high (~25%)
- Strength: simple, no labs; weakness: static (does not capture functional/social factors)
Neither score is perfect, and functional status, social support, and prior CAP readmission add predictive power that both scores under-weight.[3] Use the score as a triage flag, not a substitute for clinical judgement: a low-score patient who lives alone with new dysphagia is still high risk.
Prevention strategies overview
The multicomponent prevention bundle — what to deliver before and at discharge
Achieve clinical stability BEFORE discharge
Do not discharge on a falling trajectory. Stability criteria: improving cough/dyspnoea, afebrile for 24-48 h with <2 temperature spikes >37.8°C, able to take oral intake, neurologically back to baseline, white-cell count falling, oxygenation stable on room air or baseline oxygen, able to ambulate safely. Premature discharge is the single most preventable cause of early readmission. If a patient is readmitted within 7 days for the same pneumonia, ask "was discharge premature?" first.
Optimise chronic conditions
Treat the comorbidity that will bring them back. COPD: optimise inhalers, check technique, add a stand-by exacerbation pack, refer to pulmonary rehab. Heart failure: up-titrate GDMT (or at least diurese to euvolaemia), arrange cardiology follow-up, teach daily weights. Diabetes: agree a discharge glucose target and medication list, diabetes educator if available. CKD: renal-dose-adjust every antibiotic, nephrology follow-up. Never send a patient home on the same antibiotic if renal function has changed on the ward.
Vaccinate before discharge
Offer pneumococcal (PCV13 or the newer PCV20, then PPSV23 >=8 weeks later per local schedule), annual influenza, up-to-date COVID, and RSV for adults >=60. Vaccination is the single most cost-effective prevention act and the one most often missed. Give it before the patient leaves the building — "at the next GP visit" rarely happens in the readmitted population.
Smoking cessation
Brief advice + behavioural support + pharmacotherapy (nicotine replacement therapy, varenicline where suitable). Smoking roughly doubles CAP recurrence; cessation reduces risk toward non-smoker levels within months. Refer to a quitline and document the referral.
Medication reconciliation
Pharmacist-led reconciliation at admission AND discharge reduces medication errors and readmission. Reconcile the pre-admission list, the in-hospital changes, and the discharge prescription. Ensure the antibiotic course, duration and review date are explicit. Provide a written medication list to the patient, carer, GP and community pharmacy.
Aspiration/swallow assessment
Screen every patient with stroke, Parkinson's, dementia, prolonged intubation, or any "recurrent pneumonia". Formal SLT swallow assessment; texture-modified diet; speech-and-language follow-up; dental review for poor dentition. HOB elevation 30-45° for meals; good oral hygiene (chlorhexidine mouthcare) reduces aspiration pneumonia.
Early mobilisation and pulmonary rehab
Begin mobilisation in ICU (ABCDEF bundle) and continue on the ward. Refer to pulmonary rehabilitation — improves exercise capacity and quality of life after severe pneumonia and reduces readmission in the COPD subgroup.
Nutrition optimisation
Screen for malnutrition (MUST/MNA). Oral nutritional supplements in malnourished older inpatients reduce readmission and mortality. Aim for adequate protein and energy to rebuild ICU-acquired muscle loss; dietitian referral for high-risk patients.
Social support and follow-up
Arrange GP follow-up within 7 days (ideally scheduled before the patient leaves hospital). Offer home health/community-nurse visits for high-risk patients. Telephone follow-up at 48-72 h catches early deterioration. Confirm the patient can physically obtain and afford their medications.
Patient education and written action plan
Teach warning signs (new/worsening dyspnoea, fever, confusion, reduced oral intake) and the specific action to take (who to call, when to return). Provide a written pneumonia action plan, analogise it to a COPD/asthma plan. Educate the carer, not just the patient — essential in dementia/cognitive impairment.
Vaccination in detail
Vaccination is the cornerstone of recurrence prevention: pneumococcal and influenza vaccination together can cut recurrent CAP by approximately half.[1][6] The ATS/IDSA 2019 guideline explicitly recommends pneumococcal and influenza vaccination for all adults hospitalised with CAP, ideally before discharge.[5]
Vaccines to offer the recovering CAP patient
Pneumococcal — conjugate
PCV13 (Prevenar 13) / PCV20
- Conjugate vaccine — T-cell-dependent response, mucosal and immunological memory, effective in children and immunocompromised
- CAPiTA trial (NEJM 2015): PCV13 prevented vaccine-type pneumococcal pneumonia, invasive disease and CAP in adults >=65 (efficacy ~46% for vaccine-type CAP, ~75% for invasive disease)
- ACIP/ATS-IDSA: PCV15 or PCV20 now preferred for adults; PCV20 alone is a complete series and avoids the need for PPSV23
- Give before discharge in a vaccine-naïve patient
Pneumococcal — polysaccharide
PPSV23 (Pneumovax 23)
- Pure polysaccharide — broader serotype cover (23) but T-cell-independent (no memory, weaker in immunocompromised/elderly)
- Sequencing: if PCV13/15 given first, PPSV23 >=8 weeks later (>=1 year if immunocompetent per some schedules); if PCV20 used, PPSV23 not required
- Traditionally the backbone of the >=65 and high-risk adult programme; now being superseded by PCV20 in updated guidance
Influenza — annual
Inactivated quadrivalent
- Annual inactivated influenza vaccine for everyone >=6 months, every autumn
- Reduces influenza-attributable pneumonia, hospitalisation and death; in the elderly also reduces all-cause winter mortality
- Post-influenza bacterial pneumonia (Strep. pneumoniae, Staph aureus) is a major CAP cause — preventing influenza prevents the secondary pneumonia
- Healthcare workers: vaccinate to protect vulnerable inpatients
COVID-19
Keep up to date
- Up-to-date COVID-19 vaccination reduces severe COVID-pneumonia, hospitalisation and post-COVID bacterial superinfection
- Particularly important in elderly, comorbid and immunocompromised patients — the same population readmitted with CAP
- Offer before discharge if due; follow local guidance on boosters
RSV — older adults
Prefusion F vaccine
- RSV is an under-recognised cause of CAP and lower-respiratory-tract disease in adults >=60, with substantial morbidity and mortality
- RENOIR trial (NEJM 2023): bivalent RSV prefusion F vaccine ~83% efficacious against RSV lower-respiratory-tract disease and ~94% against severe disease in older adults
- Single dose recommended for adults >=60 (shared clinical decision-making) and for pregnant women (infant protection) per local guidance
Pneumococcal vaccine sequencing — practical summary
Vaccine-naïve adult >=65 or high-risk
Preferred modern approach: a single dose of PCV20 (or PCV15 then PPSV23 >=1 year later). Legacy approach still used widely: PCV13 first, then PPSV23 at least 8 weeks (immunocompromised) or 1 year (immunocompetent) later. The key exam point: conjugate first, polysaccharide later — never the reverse, because PPSV23 first blunts the conjugate response.
Already received PPSV23 only
Give PCV13/15/20 at least 1 year after the PPSV23 dose. If PCV15 used, a second PPSV23 is given >=1 year later (and >=8 weeks after PCV15). Document everything — the commonest real-world error is re-vaccination or missed doses because no one knows what was given.
Already received PCV13 only
Give PPSV23 at least 8 weeks (immunocompromised) or 1 year (immunocompetent) later. For adults >=65 the interval is >=1 year; for the immunocompromised it is >=8 weeks to maximise protection sooner.
Timing relative to CAP admission
Give vaccination as the patient improves and ideally before discharge — immune response is adequate once the acute inflammatory response is settling (typically when afebrile and improving). Do not delay vaccination until an arbitrary "6 weeks" if the patient is otherwise ready; the readmitted population may not return.
Smoking cessation
Smoking is one of the strongest modifiable risk factors for both initial and recurrent CAP: it impairs mucociliary clearance, alveolar macrophage function and local immune defences, and roughly doubles the risk of hospitalisation for pneumonia.[10] Cessation reduces risk toward that of never-smokers within months to years.[10]
The brief intervention that works is the 5 As — Ask, Advise, Assess, Assist, Arrange — combined with pharmacotherapy. Behavioural support plus nicotine replacement therapy (NRT) or varenicline roughly doubles quit rates. Every CAP admission is a teachable moment: patients who have just been hospitalised with pneumonia are more receptive to cessation advice. Document the quitline referral and prescribe NRT/varenicline on the discharge prescription — "I'll discuss it at the GP" loses the moment. [1]
Pulmonary rehabilitation
Pulmonary rehabilitation — supervised exercise training, education and behaviour change — improves exercise capacity, dyspnoea and quality of life after severe pneumonia and after critical illness, and reduces readmission in the COPD subgroup.[16] Programmes are typically 6-8 weeks of twice-weekly sessions. Post-ICU survivors benefit from rehab that also addresses ICU-acquired weakness, deconditioning and PICS (physical, cognitive and psychological impairment).[16]
Aspiration and swallow assessment
Recurrent pneumonia in the elderly, the neurologically impaired, and the nursing-home resident is aspiration until proven otherwise.[11] Dysphagia after stroke carries a markedly elevated pneumonia risk; meta-analytic data confirm the strong, consistent association.[11]
Assessment: bedside swallow screen for every stroke/neurological/intubated patient; formal speech-and-language therapy (SLT) assessment with videofluoroscopy or fibre-optic endoscopic evaluation of swallow (FEES) if screen positive. Interventions: texture-modified diet and thickened fluids to the safest tolerated consistency, supervised feeding, HOB elevation 30-45° for meals and 1 h after, rigorous oral hygiene (chlorhexidine mouthcare reduces aspiration pneumonia), and consideration of feeding alternatives (nasogastric vs PEG) in selected patients with persistent unsafe swallow. Address poor dentition with dental review — it is an independent aspiration-pneumonia risk factor.[2]
Early mobilisation
Prolonged bed rest drives ICU-acquired weakness, deconditioning, venous thromboembolism and functional decline — all of which delay recovery and predispose to readmission. Early mobilisation, ideally as part of the ABCDEF bundle (Assess/manage pain, Both spontaneous awakening and breathing trials, Choice of sedation, Delirium monitoring, Early mobility, Family engagement), is safe and improves outcomes.[12] Meta-analytic evidence supports early mobilisation in critically ill patients for reducing ICU-acquired weakness and improving functional outcomes.[12] Continue progressive mobilisation on the ward and into the community; refer to physiotherapy and pulmonary rehab.
Nutrition optimisation
Malnutrition is highly prevalent in CAP inpatients (especially the elderly and ICU survivors) and independently predicts readmission and mortality.[13] The NOURISH randomised trial showed that a specialised oral nutritional supplement reduced 90-day readmission and mortality in malnourished older hospitalised adults.[13] Screen every patient (MUST/MNA), involve a dietitian for high-risk patients, set protein and energy targets to rebuild ICU-acquired muscle loss, and ensure the discharge plan includes ongoing nutritional support (oral nutritional supplements, community dietitian).
Medication reconciliation
Medication errors at hospital transitions (admission and discharge) are common and independently associated with readmission and adverse drug events. Pharmacist-led medication reconciliation programmes reduce these errors and improve clinical outcomes at transitions.[14] The reconciliation must cover three points: (1) the best possible medication history on admission (what the patient was actually taking, including over-the-counter and adherence); (2) in-hospital changes and their rationale; and (3) the discharge prescription, explicitly reconciled against both. Provide a single, written, reconciled medication list to the patient, carer, GP and community pharmacy, with clear instructions on the antibiotic course (drug, dose, duration, review date) and any new/ceased/changed medications.
Social support and follow-up
The system half of the bundle. GP follow-up within 7 days (scheduled before the patient leaves hospital, with the appointment details written on the discharge summary) is the single most-studied follow-up intervention. Telephone follow-up at 48-72 h catches early deterioration and medication problems cheaply. Home health/community-nurse visits are warranted for high-risk patients (frail, socially isolated, new medications, complex dressings or oxygen). Confirm the patient can physically obtain and afford their medications — a perfect prescription that cannot be collected is worthless. A 6-week follow-up chest X-ray is recommended to ensure radiological resolution; non-resolution mandates investigation for malignancy, TB, bronchiectasis or organising pneumonia.[1]
The structured discharge bundle
Five-element pneumonia discharge bundle — deliver all five or none
1. Medication reconciliation
Pharmacist-led reconciliation of pre-admission, in-hospital and discharge medications. Explicit antibiotic course (drug/dose/duration/review date). Written medication list given to patient, carer, GP and community pharmacy. Check renal dosing, interactions and affordability.
2. Follow-up appointment scheduled
GP within 7 days (appointment booked and details on discharge summary). Outpatient/CXR follow-up at ~6 weeks for radiological resolution. Specialist referrals as needed (respiratory, cardiology, speech therapy, dietetics, pulmonary rehab).
3. Vaccination offered
Pneumococcal (PCV13/15/20 ± PPSV23), influenza, up-to-date COVID, and RSV if >=60. Administered before discharge where possible, with documentation in the discharge summary and immunisation record so it is never duplicated or omitted.
4. Smoking cessation referral
Brief advice + behavioural support + pharmacotherapy (NRT/varenicline). Documented quitline referral and prescription. Teachable moment — act on it now.
5. Written deterioration action plan
Patient and carer educated on warning signs (new/worsening dyspnoea, fever, confusion, reduced oral intake) and the specific action (who to call, when to return to hospital). Written plan provided, analogous to a COPD/asthma action plan. Carer education is essential in cognitive impairment.
A case-manager-led pneumonia care bundle in a subacute rehabilitation setting has been shown to reduce 30-day readmissions, demonstrating that bundle delivery (not any single component) is what moves the metric.[15]
Recurrent CAP — the diagnostic workup
When a patient has two or more episodes of CAP within a year (or three lifetime in the same lobe), the default assumption must be a correctable underlying cause rather than "bad luck".[1][2]
Recurrent CAP — systematic workup
1. Re-confirm it really is pneumonia
Beware the "cardiac pneumonia" (recurring pulmonary oedema masquerading as consolidation), pulmonary embolism with infarction, organising pneumonia, vasculitis with alveolar haemorrhage, and drug-induced pneumonitis. Review every CXR personally; compare with old films; consider CT chest early.
2. Structural lung disease
HRCT chest for bronchiectasis, cavitation, interstitial lung disease, and endobronchial lesion. Bronchoscopy if a foreign body, obstruction or malignancy is suspected (especially recurrent in the same lobe). Spirometry for occult COPD/asthma.
3. Aspiration risk
Bedside swallow screen; formal SLT assessment with videofluoroscopy/FEES; review dentition; consider overnight pH/impedance monitoring if reflux suspected. Look for the silent aspirations — the commonest cause in the elderly and neurologically impaired.
4. Immunodeficiency
HIV test (everyone), serum immunoglobulins (IgG, IgA, IgM — look for common variable immunodeficiency and specific antibody deficiency), IgG subclasses, vaccine response (pneumococcal antibody titres pre/post vaccination), complement (C3/C4/CH50), and CD4 count if indicated. Haematological malignancy and immunosuppressive therapy are common iatrogenic causes.
5. Cardiac
BNP/NT-proBNP and echocardiogram for heart failure — the "cardiac pneumonia". The single most over-looked reversible cause of "recurrent" lower-lobe CAP.
6. Malignancy and TB
Sputum for AFB and TB-PCR; bronchoscopy with washings/biopsy for endobronchial malignancy; CT-guided biopsy of a suspicious lesion. Non-resolving or recurrent CAP in the same lobe in a smoker is bronchogenic carcinoma until proven otherwise.
Evidence and trials
CAP readmission and recurrence prevention — the landmark evidence
CAPiTA — Bonten et al. 2015 (N Engl J Med): the pivotal RCT of 13-valent pneumococcal conjugate vaccine (PCV13) in ~85,000 Dutch adults >=65. First vaccine efficacy (VE) against vaccine-type pneumococcal pneumonia in adults (~46%), against vaccine-type invasive pneumococcal disease (~75%) and against vaccine-type non-bacteraemic CAP (~45%). The evidentiary foundation for conjugate vaccination in older adults and a central plank of post-CAP prevention.[6] RENOIR — Walsh et al. 2023 (N Engl J Med): the phase 3 RCT of a bivalent RSV prefusion F vaccine in adults >=60. VE ~83% against RSV lower-respiratory-tract disease with >=3 signs and ~94% against severe disease. Established RSV vaccination in older adults — a now-recommended element of post-CAP prevention in the elderly.[8] NOURISH — Deutz et al. 2016 (Clin Nutr): the multicentre RCT of a specialised oral nutritional supplement vs placebo in ~650 malnourished older hospitalised adults. Demonstrated a significant reduction in 90-day readmission and mortality — the evidence base for routine nutritional screening and supplementation in the malnourished CAP patient.[13] Metlay et al. 2019 (Am J Respir Crit Care Med) — ATS/IDSA CAP guideline: the current authoritative guideline for diagnosis and treatment of adults with CAP. Recommends clinical stability criteria before discharge, pneumococcal and influenza vaccination (ideally before discharge), and smoking cessation — the framework on which the modern discharge bundle is built.[5] Mekonnen et al. 2016 (BMJ Open) — medication reconciliation systematic review: meta-analysis showing pharmacist-led medication reconciliation programmes reduce medication discrepancies and improve clinical outcomes at hospital transitions — the rationale for mandatory reconciliation in the discharge bundle.[14] Cecere et al. 2012 (Respir Med): cohort study demonstrating that current smoking roughly doubles the risk of hospitalisation for pneumonia and that cessation reduces risk — the evidence base for aggressive smoking-cessation intervention at every CAP admission.[10] Banda et al. 2022 (BMC Geriatr) — dysphagia meta-analysis: confirmed the strong, consistent association between post-stroke dysphagia and pneumonia — the rationale for universal swallow screening in neurological and elderly CAP patients.[11] Zang et al. 2020 (Nurs Crit Care) — early mobilisation meta-analysis: demonstrated that early mobilisation in critically ill patients improves functional outcomes and reduces ICU-acquired weakness — supporting continued mobilisation through to discharge.[12] Granata et al. 2023 (Prof Case Manag): a case-manager-led pneumonia care bundle in a subacute rehabilitation facility reduced 30-day readmissions — direct evidence that bundle delivery (not any single element) moves the readmission metric.[15]
Red flags
Additional clinical pearls — exam-exhaustive
Common pitfalls
- Treating readmission as a single failure — it is the convergence of patient vulnerability, incomplete recovery and system gaps; a single-element intervention will not work.[15]
- Discharging before clinical stability — the most preventable cause of 7-day readmission; document the stability criteria explicitly.[5]
- Reaching for more antibiotics in "recurrent" CAP without considering heart failure, aspiration, PE, malignancy or organising pneumonia.[1][3]
- Vaccinating late or not at all — "GP will do it" is a fiction in the readmitted population; give it before discharge.[6]
- Wrong pneumococcal sequencing — polysaccharide before conjugate blunts the immune response.[6][7]
- Forgetting medication reconciliation — the second-commonest preventable readmission driver after premature discharge.[14]
- Ignoring dysphagia — the default cause of recurrent pneumonia in the elderly; missing it guarantees a return visit.[11]
- Sending home a patient who cannot obtain, afford or understand their medications — social and functional factors are real clinical risks.[15]
One-minute exam summary
CAP readmission sits at 10-20% at 30 days (target <15%, ambitious <12%) and is a publicly reported quality metric; ~half are preventable.[2][15] Risk clusters in the elderly, comorbid (COPD/heart failure/diabetes/CKD/dementia), frail, socially isolated, previous-CAP patient with severe index disease.[2][3] Prevention is a multicomponent bundle: discharge only at clinical stability; optimise comorbidities; vaccinate before discharge (pneumococcal conjugate ± polysaccharide, influenza, COVID, RSV in the elderly); smoking cessation; pharmacist-led medication reconciliation; swallow assessment for aspiration risk; early mobilisation and pulmonary rehab; nutrition optimisation; GP follow-up within 7 days plus telephone review; written deterioration action plan.[5][15] Recurrent CAP (>2/year) triggers a structural–aspiration–immune–cardiac–malignancy workup.[1][2]
References
- [1]Niederman MS, Torres A. Severe community-acquired pneumonia Eur Respir Rev, 2022.PMID 36517046
- [2]Chakrabarti B, Lane S, Jenks T, et al. Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia BMJ Open Respir Res, 2021.PMID 33771814
- [3]Toledo D, Soldevila N, Torner N, et al. Factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: a cross-sectional study in seven Spanish regions BMJ Open, 2018.PMID 29602852
- [4]Jang JG, Ahn JH. Reasons and Risk Factors for Readmission Following Hospitalization for Community-acquired Pneumonia in South Korea Tuberc Respir Dis (Seoul), 2020.PMID 32185918
- [5]Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America Am J Respir Crit Care Med, 2019.PMID 31573350
- [6]Bonten MJM, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults N Engl J Med, 2015.PMID 25785969
- [7]Cillóniz C, Amaro R, Torres A. Pneumococcal vaccination Curr Opin Infect Dis, 2016.PMID 26779776
- [8]Walsh EE, Pérez Marc G, Zareba AM, et al. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults N Engl J Med, 2023.PMID 37018468
- [9]Uyeki TM, Hui DS, Zambon M, et al. Influenza Lancet, 2022.PMID 36030813
- [10]Cecere LM, Williams EC, Sun H, et al. Smoking cessation and the risk of hospitalization for pneumonia Respir Med, 2012.PMID 22541719
- [11]Banda KJ, Chu H, Kang XL, et al. Prevalence of dysphagia and risk of pneumonia and mortality in acute stroke patients: a meta-analysis BMC Geriatr, 2022.PMID 35562660
- [12]Zang K, Chen B, Wang M, et al. The effect of early mobilization in critically ill patients: A meta-analysis Nurs Crit Care, 2020.PMID 31219229
- [13]Deutz NE, Matheson EM, Matarese LE, et al. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: A randomized clinical trial Clin Nutr, 2016.PMID 26797412
- [14]Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis BMJ Open, 2016.PMID 26908524
- [15]Granata D, Kendra M, Chiu SH. A Case Manager-Led Pneumonia Care Bundle in a Subacute Rehabilitation Facility Prof Case Manag, 2023.PMID 36662658
- [16]Kumar Khurana A, Hussain A, Goyal A, et al. Six-Week Hospital-Based Pulmonary Rehabilitation in Covid Pneumonia ICU Survivors: Experience from a Tertiary Care Center in Central India Turk Thorac J, 2022.PMID 35404239